文献速递脑血管病外科神经重症

从外科手术向血管内操作快速转变是否改善了动脉瘤性蛛网膜下腔出血的生存率?

Has a fast treatment transition from surgical to endovascular operations improved the survival of aneurysmal subarachnoid hemorrhage?
PubMed 文献 · Acta Neurochir (Wien) · 2025-02-04

该研究在赫尔辛基大学医院2012—2017年收治的665例动脉瘤性蛛网膜下腔出血患者中,比较外科治疗时代(2012—2014)与血管内治疗时代(2015—2017)的1年病死率变化。非大脑中动脉动脉瘤患者血管内治疗比例从21%升至79%,而大脑中动脉动脉瘤99%始终手术治疗;两组1年病死率均下降42%,调整风险比均为0.66,提示血管内治疗对高容量中心病死率下降的独立效应较小。

要点

  • 非大脑中动脉动脉瘤血管内治疗比例从21%升至79%,大脑中动脉动脉瘤99%全程手术。
  • 非大脑中动脉组1年病死率从14%降至8%,调整风险比0.66(95%CI 0.37-1.19)。
  • 大脑中动脉组1年病死率从15%降至9%,调整风险比0.66(95%CI 0.16-1.60)。

核心结论

  • 在快速从外科手术转向血管内治疗作为一线治疗的高容量中心,接受与未接受该转变的动脉瘤性蛛网膜下腔出血患者1年病死率下降幅度相似,提供血管内治疗对病死率下降独立效应较小的真实世界证据。

研究设计与样本

  • 研究识别赫尔辛基大学医院2012—2017年全部接受手术或血管内治疗的动脉瘤性蛛网膜下腔出血患者,以2015年治疗转变分为外科治疗时代(2012—2014)和血管内治疗时代(2015—2017),采用泊松回归模型比较非大脑中动脉与大脑中动脉患者1年病死率的时间变化趋势。
  • 通过两个外部验证登记识别赫尔辛基大学医院集水区猝死和保守治疗的动脉瘤性蛛网膜下腔出血病例,以分析手术率的一致性。

主要发现

  • 赫尔辛基大学医院集水区共665例住院动脉瘤性蛛网膜下腔出血病例,557例(84%)接受手术治疗,其中367例(66%)行外科手术,190例(34%)行血管内操作。
  • 两个治疗时代之间,非大脑中动脉病例的血管内治疗比例从21%升至79%,而大脑中动脉病例在整个研究期间99%接受外科手术治疗。
  • 在接受手术治疗的患者中,非大脑中动脉动脉瘤患者1年病死率下降42%(从14%降至8%),调整风险比0.66(95%CI 0.37-1.19);大脑中动脉动脉瘤患者1年病死率下降42%(从15%降至9%),调整风险比0.66(95%CI 0.16-1.60)。
  • 接受手术治疗患者的比例、入院时临床状况及首次CT扫描出血量随时间保持不变。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Several studies have attributed decreasing case fatality rates (CFRs) of aneurysmal subarachnoid hemorrhage (aSAH) to the gradually increasing use of endovascular treatment without considering improvements in other outcome-affecting factors. To assess the independent effect of a treatment modality on CFRs, we investigated CFR changes in a high-volume center rapidly transitioning from surgical to endovascular operations as the first-line treatment for all aSAH patients except those with middle cerebral artery (MCA) aneurysms. METHODS: We identified all surgically/endovascularly treated aSAH patients in Helsinki University Hospital (HUH) during 2012-2017. As the treatment shift occurred in 2015, we defined two treatment eras: surgical (2012-2014) and endovascular (2015-2017). We compared time-dependent changes in 1-year CFRs between non-MCA and MCA patients using a Poisson regression model. To analyze consistency in operation rates, we also identified sudden-death and conservatively treated aSAHs in the HUH catchment area via two externally validated registers. RESULTS: Of all 665 hospitalized aSAH cases in the HUH catchment area, 557 (84%) received operative treatment; 367 (66%) underwent surgical and 190 (34%) endovascular operations. Between the treatment eras, endovascular treatment for non-MCA cases increased from 21 to 79%, whereas 99% of the MCA cases were treated surgically during the whole study-period. Among the operatively treated patients, the 1-year CFRs decreased similarly in patients with non-MCA (42%; from 14 to 8%; adjusted risk ratio (aRR) = 0.66 (95% CI 0.37-1.19)) and MCA aneurysms (42%; from 15 to 9%; aRR = 0.66 (0.16-1.60)). The proportion of operatively treated patients, their clinical condition on admission, and amount of bleeding on the first CT-scan remained unchanged over time. CONCLUSIONS: We found similar CFR decreases in aSAH groups with and without undergoing a fast transition from surgery to endovascular operations, providing real-world evidence on the small independent effect of endovascular treatment on the decreasing CFRs in high-volume centers.

来源:Acta Neurochir (Wien),查看原文。版权归原作者所有。

引用

  1. Asikainen A, Rautalin I, Raj R, et al. Has a fast treatment transition from surgical to endovascular operations improved the survival of aneurysmal subarachnoid hemorrhage? Acta Neurochir (Wien). 2025. PMID: 39904810. doi:10.1007/s00701-025-06447-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。